Long-Term Outcomes of BMMSC Compared with BMMNC for Treatment of Critical Limb Ischemia and Foot Ulcer in Patients with Diabetes

Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research

(2018) Lara Lopes et al.   Stem Cell Research & Therapy

Diabetes Is Associated With Decreased Limb Survival in Patients With Critical Limb Ischemia: Pooled Data From Two Randomized Controlled Trials

(2016) Marlon I. Spreen et al.   DIABETES CARE

Increasing injection frequency enhances the survival of injected bone marrow derived mesenchymal stem cells in a critical limb ischemia animal model

(2016) Woong Chol Kang et al.   KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY

Critical Limb Ischemia: Current Trends and Future Directions

(2016) Martin Teraa et al.   Journal of the American Heart Association

Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials

(2015) S.M.O. Peeters Weem et al.   EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY

Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia

(2014) Alessandra Bura et al.   CYTOTHERAPY

The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk

(2014) Daniela Martins-Mendes et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Neovascularization Capacity of Mesenchymal Stromal Cells From Critical Limb Ischemia Patients Is Equivalent to Healthy Controls

(2014) Hendrik Gremmels et al.   MOLECULAR THERAPY

Advanced health biotechnologies in Thailand: redefining policy directions

(2013) Román Pérez Velasco et al.   Journal of Translational Medicine

Mesenchymal stromal cells for the treatment of critical limb ischemia: context and perspective

(2013) Hendrik Gremmels et al.   Stem Cell Research & Therapy

Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial

(2011) Debin Lu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

The role of stem cells in the treatment of diabetic foot ulcers

(2011) Sheila N. Blumberg et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study

(2010) Vinod K. Prasad et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Long-Term Prognosis of Diabetic Patients With Critical Limb Ischemia: A population-based cohort study

(2009) E. Faglia et al.   DIABETES CARE

Long-term clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia

(2008) Satoaki Matoba et al.   AMERICAN HEART JOURNAL

Incidence of Lower-Limb Amputation in the Diabetic and Nondiabetic General Population: A 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations

(2008) A. Johannesson et al.   DIABETES CARE

Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia

(2008) Jean-Paul Duong Van Huyen et al.   MODERN PATHOLOGY